Neuroprotective Effects of Brain-Derived Neurotrophic Factor (BDNF) on Hearing in Experimental Pneumococcal Meningitis

Abstract

Bacterial meningitis is still one of the most common causes of acquired profound sensorineural deafness in children despite antibiotic treatment. We investigated the neuroprotective effects of brain-derived neurotrophic factor on hearing function in experimental bacterial meningitis. We implanted stainless steel tubes into both cerebral ventricles of Sprague-Dawley rats aged 21 days. Bacterial meningitis was induced by inoculating a strain of serotype III Streptococcus pneumoniae into the cisterna magna. Six micrograms per day of brain-derived neurotrophic factor (groups 1 and 3) or albumin (groups 2 and 4) was injected into the cerebral ventricles 24 hours after or before infection, respectively, for a duration of 7 days. Additionally, all rats received antibiotic subcutaneous treatment starting 24 hours after infection for 7 days. Brainstem auditory evoked potentials were recorded 24 hours before and 24 hours after infection and after 7 days of treatment with brain-derived neurotrophic factor or placebo and antibiotics, respectively, to determine hearing threshold. Our results showed that the hearing thresholds of animals in each group increased significantly 24 hours after infection compared with the results recorded 24 hours before infection (P < .01). After 7 days of treatment with brain-derived neurotrophic factor, brainstem auditory evoked potential responses recurred in 16 ears when stimulated at 75 dB hearing level in groups 1 and 3. Their hearing thresholds significantly decreased compared with the control group 2 (P < .05) and group 4 (P < .01). However, 13 of 14 ears absent brainstem auditory evoked potential responses could still not be identified at 75 dB hearing level in control groups 2 and 4. The improvement of the hearing thresholds in group 3 (treated before infection) was greater than that of group 1 (treated after infection) (P < .05), but there was no significant difference found between the control groups before and after infection (P > .05). Our study supports the hypothesis that the administration of exogenous brain-derived neurotrophic factor can be effective in preventing or treating hearing loss following bacterial meningitis. ( J Child Neurol 2005;20:51—56).

Get full access to this article

View all access options for this article.

References

Baraff LJ , Lee SI , Schriger DL : Outcome of bacterial meningitis in children: A metaanalysis. Pediatr Infect Dis J 1993;12:389—394.

Grimwood K. , Anderson P. , Anderson V. , et al: Twelve year outcome following bacterial meningitis: Further evidence for persisting effects. Arch Dis Child 2000;83:111—116.

Townsend GC , Scheld WM : Adjunctive therapy for bacterial meningitis: Rationale for use, current status, and prospects for the future. Clin Infect Dis 1993;17(Suppl 2):S537—S549.

Jayarajan V. , Rangan S. : Delayed deterioration of hearing following bacterial meningitis. J Laryngol Otol 1999 ;113:1011—1014.

Nadol JB : Hearing loss as a sequel of meningitis. Laryngoscope 1978;88:739—755.

Merchant SN , Gopen Q. : A human temporal bone study of acute bacterial meningogenic labyrinthitis . Am J Otol 1996;17:375—385.

Rosenthal A. , Goeddel DV , Nguyen T. , et al: Primary structure and biological activity of human brain-derived neurotrophic factor. Endocrinology 1991;129:1289—1294.

Bothwell M. : Function interactions of neurotrophins and neurotrophin receptors . Annu Rev Neurosci 1995; 18:223-253.

Riaz SS , Tomlinson DR : Neurotrophic factors in peripheral neuropathies: Pharmacological strategies . Prog Neurobiol 1996;49: 125—143.

10.

Li L. , Shui QX , Zhao ZY : Regulation of brain-derived neurotrophic factor (BDNF) expression following antibiotic treatment of experimental bacterial meningitis. J Child Neurol 2003;18:828—834.

11.

Cheng Y. , Gidday JM , Yan Q. , et al: Marked age-dependent neuro-protection by brain derived neurotrophic factor against neonatal hypoxic ischemic brain injury. Ann Neurol 1997;41:521—529.

12.

Li L. , Shui QX , Lai AD , et al: Study on animal model of bacterial meningitis in infancy rats. J Appl Clin Pediatr 2002;17:237—238.

13.

Bradley W. , Kesser MD , George T. , et al: Time course of hearing loss in an animal model of pneumococcal meningitis. Otolaryngol Head Neck Surg 1999 ;120:628—637.

14.

Osborne MP , Comis SD , Tarlow MJ , et al: The cochlear lesion in experimental bacterial meningitis of the rabbit. Int J Exp Pathol 1995;76:317—330.

15.

Kapoor RK , Kumar R. , Misra PK , et al: Brainstem auditory evoked response in children with bacterial meningitis. Indian J Pediatr 1996;63:217—225.

16.

Bhatt S. , Lauretano A. , Cabellos C. , et al: Progression of hearing loss in experimental pneumococcal meningitis: Correlation with cerebrospinal fluid cytochemistry. J Infect Dis 1993 ;167:675—683.

17.

Rappaport JM , Bhatt SM , Kimura RS , et al: Electron microscopic temporal bone histopathology in experimental pneumococcal meningitis. Ann Otol Rhinol Laryngol 1999;108:537—547.

18.

Altschuler RA , Cho Y. , Ylikoski J. : Rescue and regrowth of sensory nerves following deafferentation by neurotrophic factors. Ann N Y Acad Sci 1999;884:305—311.

19.

Marzella PL , Gillespie LN : Role of trophic factors in the development, survival and repair of primary auditory neurons. Clin Exp Pharmacol Physiol 2002;29:363—371.

20.

Hartnick CJ , Staecker H. , Malgrange B. , et al: Neurotrophic effects of BDNF and CNTF, alone and in combination, on postnatal day 5 rat acoustic ganglion neurons . J Neurobiol 1996 ;30:246—254.

21.

Malgrange B. , Lefebvre P. , Van de Water TR , et al: Effects of neurotrophins on early auditory neurones in cell culture. Neuroreport 1996;7:913—917.

22.

Miller JM , Chi DH , O' Keeffe LJ , et al: Neurotrophins can enhance spiral ganglion cell survival after inner hair cell loss. Int J Dev Neurosci 1997 ;15:631—643.

23.

Ruan RS , Leong SK , Mark I. , Yeoh KH : Effects of BDNF and NT-3 on hair cell survival in guinea pig cochlea damaged by kanamycin treatment. Neuroreport 1999; 10:2067-2071.

24.

Lopez I. , Honrubia V. , Lee SC , et al: The protective effect of brain-derived neurotrophic factor after gentamicin ototoxicity. Am J Otol 1999;20:317—324.

25.

Shinohara T. , Bredberg G. , Ulfendahl M. , et al: Neurotrophic factor intervention restores auditory function in deafened animals. Proc Natl Acad Sci U S A 2002;99:1657—1660.

26.

Barde YA : Trophic factors and neuronal survival. Neuron 1989;2:1525—1534.

27.

Thoenen H. : The changing scene of neurotrophic factors. Trends Neurosci 1991;14:165—170.

28.

Persson, H. , Ibanez CF : Role and expression of neurotrophins and the trk family of tyrosine kinase receptors in neural growth and rescue after injury. Curr Opin Neurol Neurosurg 1993 ,6:11—18.

29.

Pirvola U. , Arumae U. , Moshnyakov M. , et al: Coordinated expression and function of neurotrophins and their receptors in the rat inner ear during target innervation. Hear Res 1994;75:131—144.

30.

Gestwa G. , Wiechers B. , Zimmermann U. , et al: Differential expression of trkB.T1 and trkB.T2, truncated trkC, and p75(NGFR) in the cochlea prior to hearing function. J Comp Neurol 1999; 414:33—49.

31.

Staecker H. , Gabaizadeh R. , Federoff H. , et al: Brain-derived neurotrophic factor gene therapy prevents spiral ganglion degenerationafterhaircellloss . Otolaryngol Head Neck Surg 1998,119:7—13.